Abstract
Aim:
To investigate the possible roles of peroxisome proliferator-activated receptor α (PPARα) and the signal pathway regulating the transcription of PPARα in the cardiomyocyte differentiation course of murine embryonic stem (ES) cells in vitro.
Methods:
The expression of PPARα during cardiomyocyte differentiation was analyzed using both Western blotting and immunofluorescence. Cardiac specific genes and sarcomeric proteins were evaluated when embryoid bodies were challenged with PPARα specific inhibitor GW6471 at different time courses. The phosphorylation of p38 mitogen-activated protein kinase (MAPK) was studied in the differentiation process, and its specific inhibitor SB203580 was employed to study the function of p38 MAPK on cardiac differentiation and the expression of PPARα.
Results:
The expression of PPARα was observed to be at a low level in undifferentiated ES cells and markedly induced with the appearance of beating clusters. The inhibition of PPARα by its specific inhibitor GW6471 (1 × 10−5 mol/L) significantly prevented cardiomyocyte differentiation and resulted in the reduced expression of cardiac sarcomeric proteins (ie α-actinin, troponin-T) and specific genes (ie α-MHC, MLC2v) in a time-dependent manner. In the differentiation course, p-p38 MAPK was maintained at a high level from d 3 followed by a decrease from d 10. The inhibition of the p38 MAPK pathway by SB203580 between d 3 and d 7 efficiently prevented cardiomyocyte differentiation and resulted in the capture of the upregulation of PPARα.
Conclusion:
Taken together, these results showed a close association between PPARα and cardiomyocyte differentiation in vitro, and p38 MAPK was partly responsible for the regulation of PPARα.
Similar content being viewed by others
Article PDF
References
Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 1998; 4: 1269–75.
Leone TC, Weinheimer CJ, Kelly DP . A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 1999; 96: 7473–8.
Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP . Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996; 94: 2837–42.
Sack MN, Disch DL, Rockman HA, Kelly DP . A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc Natl Acad Sci USA 1997; 94: 6438–43.
Brandt JM, Djouadi F, Kelly DP . Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem 1998; 273: 23786–92.
Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D, et al. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 1998; 273: 8560–3.
Yu GS, Lu YC, Gulick T . Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Ibeta gene promoters by fatty acid enzyme substrate. J Biol Chem 1998; 273: 32901–9.
Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 1994; 91: 7355–9.
Ono K, Han J . The p38 signal transduction pathway: activation and function. Cell Signal 2000; 12: 1–13.
Issemann I, Green S . Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645–50.
Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999; 4: 611–7.
Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, et al. Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell 1998; 1: 465–70.
Park KS, Lee RD, Kang SK, Han SY, Park KL, Yang KH, et al. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. Exp Cell Res 2004; 297: 424–33.
Steinmetz M, Quentin T, Poppe A, Paul T, Jux C . Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat. Basic Res Cardiol 2005; 100: 263–9.
Braissant O, Wahli W . Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology 1998; 139: 2748–54.
Davidson SM, Morange M . Hsp25 and the p38 MAPK pathway are involved in differentiation of cardiomyocytes. Dev Biol 2000; 218: 146–60.
Natale DR, Paliga AJ, Beier F, D'Souza SJ, Watson AJ . p38 MAPK signaling during murine preimplantation development. Dev Biol 2004; 268: 76–88.
Aouadi M, Bost F, Caron L, Laurent K, Le Marchand Brustel Y, Binetruy B, et al. p38 mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis. Stem Cells 2006; 24: 1399–406.
Oskouian B, Sooriyakumaran P, Borowsky AD, Crans A, Dillard-Telm L, Tam YY, et al. Sphingosine-1–phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proc Natl Acad Sci USA 2006; 103: 17384–9.
Cai B, Chang SH, Becker EB, Bonni A, Xia Z . p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65. J Biol Chem 2006; 281: 25215–22.
Eriksson M, Leppa S . Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardio-myocyte differentiation of P19 embryonal carcinoma cells. J Biol Chem 2002; 277: 15992–6001.
Wobus AM, Wallukat G, Hescheler J . Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 1991; 48: 173–82.
Metzger JM, Lin WI, Samuelson LC . Vital staining of cardiac myocytes during embryonic stem cell cardiogenesis in vitro. Circ Res 1996; 78: 547–52.
Hescheler J, Fleischmann BK, Lentini S, Maltsev VA, Rohwedel J, Wobus AM, et al. Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis. Cardiovasc Res 1997; 36: 149–62.
Metzger JM, Lin WI, Johnston RA, Westfall MV, Samuelson LC . Myosin heavy chain expression in contracting myocytes isolated during embryonic stem cell cardiogenesis. Circ Res 1995; 76: 710–9.
Scholz G, Pohl I, Genschow E, Klemm M, Spielmann H . Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs 1999; 165: 203–11.
Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 2002; 415: 813–7.
Kraft CS, LeMoine CM, Lyons CN, Michaud D, Mueller CR, Moyes CD, et al. Control of mitochondrial biogenesis during myogenesis. Am J Physiol Cell Physiol 2006; 290: C1119–27.
Wei H, Juhasz O, Li J, Tarasova YS, Boheler KR . Embryonic stem cells and cardiomyocyte differentiation: phenotypic and molecular analyses. J Cell Mol Med 2005; 9: 804–17.
Attardi G, Schatz G . Biogenesis of mitochondria. Annu Rev Cell Biol 1988; 4: 289–333.
Herzberg NH, Middelkoop E, Adorf M, Dekker HL, van Galen MJ, van den Berg M, et al. Mitochondria in cultured human muscle cells depleted of mitochondrial DNA. Eur J Cell Biol 1993; 61: 400–8.
Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237–45.
Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipo-protein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999; 341: 410–8.
Kanno S, Kim PK, Sallam K, Lei J, Billiar TR, Shears LL II . Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc Natl Acad Sci USA 2004; 101: 12277–81.
Pineda Torra I, Jamshidi Y, Flavell DM, Fruchart JC, Staels B . Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element. Mol Endocrinol 2002; 16: 1013–28.
Barger PM, Browning AC, Garner AN, Kelly DP . p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J Biol Chem 2001; 276: 44495–501.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Sciences Foundation of China (No 30171121, 30472112, 30672564), the Key Grant of the Chinese Ministry of Education (No 03088), and the International Joint Key Grant of Zhejiang Province (No 2003C24005).
Rights and permissions
About this article
Cite this article
Ding, L., Liang, Xg. & Lou, Yj. Time-dependence of cardiomyocyte differentiation disturbed by peroxisome proliferator-activated receptor α inhibitor GW6471 in murine embryonic stem cells in vitro. Acta Pharmacol Sin 28, 634–642 (2007). https://doi.org/10.1111/j.1745-7254.2007.00558.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00558.x
Keywords
This article is cited by
-
Transcriptome analysis of intestine from alk-SMase knockout mice reveals the effect of alk-SMase
Cancer Cell International (2022)